Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Saved in:
| Title: | Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats. |
|---|---|
| Authors: | Honore P; Physiopharmacologie du Système Nerveux, l'Institut National de la Santé et de la Recherche Médicale U161, and Ecole Pratique des HautesEtudes, Paris, France., Buritova J, Fournié-Zaluski MC, Roques BP, Besson JM |
| Source: | The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1997 Apr; Vol. 281 (1), pp. 208-17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print Cited Medium: Print ISSN: 0022-3565 (Print) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 9103499 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Honore+P%22">Honore P</searchLink>; Physiopharmacologie du Système Nerveux, l'Institut National de la Santé et de la Recherche Médicale U161, and Ecole Pratique des HautesEtudes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Buritova+J%22">Buritova J</searchLink><br /><searchLink fieldCode="AU" term="%22Fournié-Zaluski+MC%22">Fournié-Zaluski MC</searchLink><br /><searchLink fieldCode="AU" term="%22Roques+BP%22">Roques BP</searchLink><br /><searchLink fieldCode="AU" term="%22Besson+JM%22">Besson JM</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 1997 Apr; Vol. 281 (1), pp. 208-17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0022-3565 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=9103499 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 208 Titles: – TitleFull: Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Honore P – PersonEntity: Name: NameFull: Buritova J – PersonEntity: Name: NameFull: Fournié-Zaluski MC – PersonEntity: Name: NameFull: Roques BP – PersonEntity: Name: NameFull: Besson JM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 1997 Apr Type: published Y: 1997 Identifiers: – Type: issn-print Value: 0022-3565 Numbering: – Type: volume Value: 281 – Type: issue Value: 1 Titles: – TitleFull: The Journal of pharmacology and experimental therapeutics Type: main |
| ResultId | 1 |